It is very uncertain whether azoles changes adverse effects Reported by investigators 'and' or 'or' participants compared with allylamines (very low certainty).
It is very uncertain whether azoles changes adverse effects Reported by investigators 'and' or 'or' participants compared with moderate‐potent corticosteroid/azole combinations (very low certainty).
It is very uncertain whether azoles changes adverse effects Reported by investigators 'and' or 'or' participants compared with benzylamines (very low certainty).
It is very uncertain whether terbinafine 1% cream/gel changes adverse effects Reported by investigators 'and' or 'or' participants compared with placebo cream/gel (very low certainty).
It is very uncertain whether azoles changes adverse effects Reported by investigators 'and' or 'or' participants compared with placebo (very low certainty).
It is very uncertain whether naftifine 1% cream once or twice daily changes adverse effects Reported by investigators 'and' or 'or' participants compared with placebo cream once or twice daily (very low certainty).